LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 65 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2020. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $257,000 | -24.6% | 80,615 | +0.7% | 0.00% | – |
| Q1 2022 | $341,000 | -3.4% | 80,053 | +5.3% | 0.00% | – |
| Q4 2021 | $353,000 | +13.5% | 76,006 | -2.4% | 0.00% | – |
| Q3 2021 | $311,000 | -2.2% | 77,839 | +4.7% | 0.00% | – |
| Q2 2021 | $318,000 | -67.1% | 74,312 | -67.4% | 0.00% | – |
| Q1 2021 | $967,000 | -0.5% | 228,088 | -8.9% | 0.00% | – |
| Q4 2020 | $972,000 | -12.0% | 250,427 | -8.6% | 0.00% | – |
| Q3 2020 | $1,104,000 | -19.5% | 273,948 | -14.9% | 0.00% | – |
| Q2 2020 | $1,371,000 | +9.5% | 321,968 | +7.9% | 0.00% | – |
| Q1 2020 | $1,252,000 | +6.9% | 298,285 | +0.1% | 0.00% | – |
| Q4 2019 | $1,171,000 | -55.6% | 298,063 | -0.6% | 0.00% | -100.0% |
| Q3 2019 | $2,639,000 | +3.3% | 299,889 | +8.6% | 0.00% | 0.0% |
| Q2 2019 | $2,555,000 | +44.8% | 276,154 | +0.7% | 0.00% | – |
| Q1 2019 | $1,764,000 | -37.2% | 274,274 | -7.9% | 0.00% | -100.0% |
| Q4 2018 | $2,809,000 | -54.1% | 297,893 | -2.1% | 0.00% | 0.0% |
| Q3 2018 | $6,125,000 | -29.8% | 304,226 | +1.8% | 0.00% | -50.0% |
| Q2 2018 | $8,719,000 | +16.9% | 298,883 | +19.3% | 0.00% | 0.0% |
| Q1 2018 | $7,459,000 | -7.7% | 250,501 | -0.3% | 0.00% | 0.0% |
| Q4 2017 | $8,084,000 | -7.7% | 251,193 | -0.3% | 0.00% | 0.0% |
| Q3 2017 | $8,758,000 | +14.6% | 251,844 | -1.9% | 0.00% | 0.0% |
| Q2 2017 | $7,641,000 | +26.1% | 256,640 | +26.4% | 0.00% | 0.0% |
| Q1 2017 | $6,058,000 | +75.1% | 202,962 | +2.8% | 0.00% | +100.0% |
| Q4 2016 | $3,460,000 | -22.2% | 197,420 | +5.6% | 0.00% | 0.0% |
| Q3 2016 | $4,447,000 | +46.6% | 186,972 | -1.4% | 0.00% | 0.0% |
| Q2 2016 | $3,034,000 | -14.8% | 189,583 | +11.3% | 0.00% | 0.0% |
| Q1 2016 | $3,562,000 | -21.2% | 170,290 | +1.7% | 0.00% | 0.0% |
| Q4 2015 | $4,520,000 | +15.2% | 167,408 | +18.5% | 0.00% | 0.0% |
| Q3 2015 | $3,925,000 | +292.9% | 141,219 | +246.4% | 0.00% | – |
| Q2 2015 | $999,000 | +146.7% | 40,769 | +84.3% | 0.00% | – |
| Q1 2015 | $405,000 | +34.6% | 22,125 | +35.5% | 0.00% | – |
| Q4 2014 | $301,000 | +110.5% | 16,325 | +9.5% | 0.00% | – |
| Q3 2014 | $143,000 | – | 14,913 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,914,970 | $81,007,000 | 29.87% |
| RTW INVESTMENTS, LP | 1,080,331 | $30,022,000 | 9.33% |
| Avoro Capital Advisors LLC | 804,299 | $22,351,000 | 5.81% |
| ACUTA CAPITAL PARTNERS, LLC | 122,222 | $3,397,000 | 1.97% |
| Broadfin Capital, LLC | 1,095,373 | $30,440,000 | 1.69% |
| Belmont Global Advisors, Inc. | 35,000 | $973,000 | 1.65% |
| P.A.W. CAPITAL CORP | 48,000 | $1,334,000 | 1.53% |
| Perceptive Advisors | 1,309,030 | $36,378,000 | 1.45% |
| Iguana Healthcare Management, LLC | 125,000 | $3,474,000 | 1.37% |
| EAM Investors, LLC | 97,350 | $2,705,000 | 0.43% |